BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Somatic Cell Gene Editing - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scge.mcw.edu
X-WR-CALDESC:Events for Somatic Cell Gene Editing
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240910
DTEND;VALUE=DATE:20240913
DTSTAMP:20260421T060136
CREATED:20240612T154901Z
LAST-MODIFIED:20240612T154901Z
UID:4286-1725926400-1726185599@scge.mcw.edu
SUMMARY:Gene Therapy for Ophthalmic Disorders Summit
DESCRIPTION:Join 100+ industry leaders at the 5th Gene Therapy for Ophthalmic Disorders Summit to uncover cutting-edge gene therapy breakthroughs. Harness the latest developments in vector engineering to target retinal cells more effectively with higher transduction efficiency. Understand the crucial role of endpoint selection to clearly demonstrate product efficacy to the FDA & EMA. Understand the risk-benefit profiles of different ocular administration routes including intravitreal\, subretinal\, and suprachoroidal delivery to choose the best option for your specific indication. Learn from successful clinical trials as well as where trials have fallen short of expectations to take forward crucial lessons learnt on progressing a gene therapy rapidly through the clinic without compromising on safety. \nBoston\, MA
URL:https://scge.mcw.edu/events/gene-therapy-for-ophthalmic-disorders-summit/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/06/Screenshot-2024-06-12-104844.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240910T100000
DTEND;TZID=America/Chicago:20240910T103000
DTSTAMP:20260421T060136
CREATED:20240820T163056Z
LAST-MODIFIED:20240820T163056Z
UID:4442-1725962400-1725964200@scge.mcw.edu
SUMMARY:Webinar: Considerations in leveraging the Universal AAV Standard for dPCR to assess AAV genomes quantity and quality
DESCRIPTION:This webinar will explore the utility of a Universal AAV Standard in assessing the quantity and genomic integrity of AAV vectors. The Universal AAV Standard combines multiple target sites for commonly used promoters\, poly(A) regions and functional CDS. Stacking of these elements in Universal AAV Standard allows it to serve as a single positive control for evaluating the performance of dPCR assays and assessing the quantity\, quality\, and genomic integrity of AAV genomes. \nRegister at https://www.workcast.com/register?cpak=5801990019211892&referrer=tw  \n 
URL:https://scge.mcw.edu/events/webinar-considerations-in-leveraging-the-universal-aav-standard-for-dpcr-to-assess-aav-genomes-quantity-and-quality/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/Screenshot-2024-08-20-112916.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240919
DTEND;VALUE=DATE:20240921
DTSTAMP:20260421T060136
CREATED:20240808T143712Z
LAST-MODIFIED:20240808T143712Z
UID:4358-1726704000-1726876799@scge.mcw.edu
SUMMARY:HI-POCT 2024
DESCRIPTION:IEEE-EMBS International Conference on Health Innovations in Point of Care Technology (IEEE HI-POCT) is the premier conference in the areas of Health innovations in point-of-care technologies. In its eighth year\, this IEEE EMB Strategic Conference will emphasize funding opportunities and the promise and pitfalls of the journey from idea to patient. The conference will provide a strategic forum in which clinicians\, industry experts\, innovation experts\, researchers\, and students will examine how to define unmet clinical needs and successfully travel along the innovation cycle toward commercialization and patient impact. Clinical\, technological\, regulatory\, and marketing aspects of this learnable process will be stressed. Expert panels will discuss learnings in the development\, translation\, and commercialization of technologies and challenges in bringing medical care innovation to community health. \nTuscon\, AZ \n\nHome \n\n 
URL:https://scge.mcw.edu/events/hi-poct-2024/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/Screenshot-2024-08-08-093624.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240920T073000
DTEND;TZID=America/Chicago:20240920T173000
DTSTAMP:20260421T060136
CREATED:20240710T134050Z
LAST-MODIFIED:20240710T134155Z
UID:4307-1726817400-1726853400@scge.mcw.edu
SUMMARY:The Safe and Effective Practice of AAV Gene Therapy
DESCRIPTION:Join the Clinical In Vivo Gene Therapy (CIGT) team at Children’s Hospital of Philadelphia for an exciting one-day educational symposium\, as we provide fundamental knowledge on the safe and effective practice of adeno-associated virus (AAV) gene therapy across medical specialties. SCGE researchers Lindsey George\, Beverly Davidson\, and Rebecca Ahrens-Nicklas are scheduled to be speaking at the event. \nFriday September 20\, 2024 || Philadelphia\, PA \nView the registration info here
URL:https://scge.mcw.edu/events/the-safe-and-effective-practice-of-aav-gene-therapy/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/07/Screenshot-2024-07-10-083625.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240920T100000
DTEND;TZID=America/Chicago:20240920T153000
DTSTAMP:20260421T060136
CREATED:20240723T134352Z
LAST-MODIFIED:20240723T134352Z
UID:4333-1726826400-1726846200@scge.mcw.edu
SUMMARY:Meeting 1: Patient and Care Partner Perspectives on Safety Considerations for Approved Gene Therapy Treatments for Rare Diseases
DESCRIPTION:The FDA Center for Biologics Evaluation and Research (CBER) is hosting a public patient listening meeting and opening a docket to better understand patient and care partner perspectives on safety considerations and long-term follow-up for approved gene therapy treatments for rare diseases. \nThe objectives of this listening meeting are to hear from patients and care partners on their perspectives on short-term and long-term risks of approved gene therapy products\, to learn what types of information patients would find helpful in their decision-making when considering gene therapy\, to learn about their considerations and experience with participating in long-term studies after receiving a gene therapy\, and to help inform patient-centered protocols for long-term studies that include gene therapy outcomes.  The meeting will be divided into two sessions. \nRegister for the Zoom meeting here: https://web.cvent.com/event/0b2da86e-f7d1-4288-9d11-2cb9cabe87c5/regProcessStep \nRegistration will close on Thursday\, September 19\, 2024\, at 11:59 pm ET. A recording and other relevant meeting materials will be posted online following the event.
URL:https://scge.mcw.edu/events/meeting-1-patient-and-care-partner-perspectives-on-safety-considerations-for-approved-gene-therapy-treatments-for-rare-diseases/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/07/Screenshot-2024-07-23-084318.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240923
DTEND;VALUE=DATE:20240925
DTSTAMP:20260421T060136
CREATED:20240820T162113Z
LAST-MODIFIED:20240820T162211Z
UID:4435-1727049600-1727222399@scge.mcw.edu
SUMMARY:2024 Policy Summit
DESCRIPTION:The 2024 Policy Summit will include experts on topics such as global regulatory harmonization\, clinical development challenges\, the payment policy landscape\, CGT investment insights\, and more. Join other cell and gene therapy professionals at this 1.5-day event to learn about public policies and regulatory trends impacting the field. \nWashington DC/Hybrid \nRegister at https://www.asgct.org/advocacy/events-and-opportunities/policy-summit/registration \n 
URL:https://scge.mcw.edu/events/2024-policy-summit/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/ASGCT-policy-summit.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240924
DTEND;VALUE=DATE:20240927
DTSTAMP:20260421T060136
CREATED:20240808T145035Z
LAST-MODIFIED:20240808T145035Z
UID:4365-1727136000-1727395199@scge.mcw.edu
SUMMARY:3rd Annual Lipid Nanoparticles Development Summit Europe
DESCRIPTION:The 3rd Lipid Nanoparticles Development Summit Europe is your premier forum to collaborate with a carefully curated community of experts across Discovery\, Characterisation\, Translatability\, Formulation\, Biodistribution\, Manufacturing and much more. These industry leaders are gathering in Berlin this September to bring the greatest challenges in LNP development to the fore\, tackling them head on to ensure 2024 is the year of the LNP. \nBerlin\, Germany \nLearn more at: https://lipid-nanoparticle-development-europe.com/ 
URL:https://scge.mcw.edu/events/3rd-annual-lipid-nanoparticles-development-summit-europe/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/08/Screenshot-2024-08-08-095000.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240925
DTEND;VALUE=DATE:20240929
DTSTAMP:20260421T060136
CREATED:20240102T191519Z
LAST-MODIFIED:20240102T192205Z
UID:3427-1727222400-1727567999@scge.mcw.edu
SUMMARY:Week in RARE
DESCRIPTION:Week in RARE\, presented by Global Genes\, features the RARE Health Equity Forum and the RARE Advocacy Summit. \nThe RARE Health Equity Forum convenes stakeholders in the rare disease space to identify ways in which we can better serve marginalized populations within the rare disease community. In its third year\, the event will be focused on the theme of “Equity In Action”. \nThe RARE Advocacy Summit provides the opportunity to forge meaningful connections with others in the rare disease community for future collaboration. Sessions provide attendees with insights about the latest in rare disease innovations\, best practices for advocating on an individual and organizational level\, and actionable strategies they can take home and implement immediately to accelerate change. \nFind more information at: https://www.globalgenes.org/week-in-rare/
URL:https://scge.mcw.edu/events/rare-health-equity-forum/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/01/gg-logo-400x172_globalgenes.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240925
DTEND;VALUE=DATE:20240928
DTSTAMP:20260421T060136
CREATED:20240711T170555Z
LAST-MODIFIED:20240711T170555Z
UID:4318-1727222400-1727481599@scge.mcw.edu
SUMMARY:RESI Boston 2024
DESCRIPTION:The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain\, connecting start-ups with 10 categories of global investors across the silos of drugs\, devices\, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups\, those seeking grants\, seed and angel capital\, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare. \n9/25 – Boston \n9/26 and 9/27 – Virtual \nhttps://resiconference.com/ 
URL:https://scge.mcw.edu/events/resi-boston-2024/
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2024/07/Screenshot-2024-07-11-120532.png
END:VEVENT
END:VCALENDAR